AbbVie and Baxalta have many similarities. Here are the key differences that make one a better investment than the other.
Here are some of the best managed health care stocks our algorithm says you should consider looking at.
Biotech columnist Adam Feuerstein answers readers' questions about health care.
Advaxis back on investor good books after Broadfin healthcare fund doubled their position after stock's 40% decline
Disney (DIS) was leading a sell-off among media stocks in midday trading Thursday after Bernstein downgraded the world's largest entertainment company on declining affiliate fees.
The slow commercial launch of Afrezza, MannKind's inhaled mealtime insulin, continues to be the root cause of the company's balance-sheet woes.
Corbus Pharmaceuticals (CRBP) shares are climbing after the company's systemic sclerosis treatment candidate was given FDA fast track status.
Speculative biotech stocks that were huge winners for healthcare investors earlier this year are now down significantly from their 52-week highs.
Warren Buffett may not own Apple’s (AAPL) stock, but the consumer technology giant is right up the famed investor’s alley, said Phil Ash, CEO of Baton Investing.
The stock market is due for a correction, but that would only present a buying opportunity for investors, according to David Rosenberg, Chief Economist and Strategist at Gluskin Sheff.
Kevin Kinsella says valuations of 'unicorn' companies have become outlandish. These start-up technology companies blessed with billion-dollar valuations better buckle up.
Startup technology companies blessed with billion dollar valuations better buckle up. It’s going to be a bumpy ride in the coming months for the so-called 'unicorn' set.
In Thursday's Analysts' Actions, Wall Street firms are giving Merck & Co. (MRK), Cisco Systems (CSCO), and Alibaba (BABA) some attention.
These stocks have had a really good run, says Wedbush Securities, which is holding its annual health care investment conference in New York.
Investors are most excited about Bluebird Bio (BLUE) and Pacira Pharmaceuticals (PCRX), according to Wedbush Securities, which is holding its annual healthcare investment conference in New York.
Select the service that is right for you!COMPARE ALL SERVICES
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV